Schrödinger Inc.

NASDAQ: SDGR · Real-Time Price · USD
23.53
-2.45 (-9.43%)
At close: May 06, 2025, 3:59 PM
24.08
2.34%
After-hours: May 06, 2025, 06:54 PM EDT
-9.43%
Bid 23.5
Market Cap 1.73B
Revenue (ttm) 207.54M
Net Income (ttm) -187.12M
EPS (ttm) -2.57
PE Ratio (ttm) -9.16
Forward PE -12.1
Analyst Buy
Ask 24.91
Volume 1,216,814
Avg. Volume (20D) 1,180,638
Open 25.45
Previous Close 25.98
Day's Range 23.27 - 25.49
52-Week Range 16.60 - 28.47
Beta 1.84

About SDGR

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on...

Sector Healthcare
IPO Date Feb 6, 2020
Employees 891
Stock Exchange NASDAQ
Ticker Symbol SDGR
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $29.5, which is an increase of 25.37% from the latest price.

Stock Forecasts

Next Earnings Release

Schrödinger Inc. is scheduled to release its earnings on May 7, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+27.42%
Shares of healthcare technology stocks are trading... Unlock content with Pro Subscription
2 months ago
+2.53%
Schrodinger shares are trading higher after the company reported better-than-expected Q4 financial results.